IP Library › Granted Patent US 10,519,496
Granted Patent B2
US 10,519,496 · App. 15/470,801 · Granted Dec 31, 2019

Labelled nucleotides

Inventors: Shankar Balasubramanian (Cambridge, GB); Colin Lloyd Barnes (Cambridge, GB); Xiaohai Liu (Cambridge, GB); Xiaolin Wu (Cambridge, GB); John Milton (Cambridge, GB)
Assignee: Illumina Cambridge Limited
C12Q1/6869C07H19/10C07H19/20C07H21/00C12P19/34C12Q1/6806C12Q1/6818C12Q1/6823C12Q1/6834C12Q1/6874C12Q1/6876C12Q2525/186
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,519,496
App. No.
15/470,801
Granted
Dec 31, 2019
Kind
B2
Abstract

Nucleosides and nucleotides are disclosed that are linked to detectable labels via a cleavable linker group.

Claims (23)

1. A nucleotide comprising a base linked to a detectable label via a cleavable linker comprising an azido group, wherein the nucleotide further comprises a ribose or deoxyribose moiety, said ribose or deoxyribose comprising an azido protecting group attached to the 2′ or 3′ oxygen atom.

2. The nucleotide of claim 1 , wherein the base is a purine, a deazapurine, or a pyrimidine.

3. The nucleotide of claim 2 , wherein the base is attached to the cleavable linker at the 7-position of the purine or the 5-position of the pyrimidine.

4. The nucleotide of claim 1 , wherein same chemical conditions may be used to effect cleavage of the cleavable linker and to remove the azido protecting group.

5. The nucleotide of claim 1 , wherein the ribose or deoxyribose moiety comprises an unprotected 3′ hydroxyl moiety.

6. The nucleotide of claim 5 , wherein the detectable label prevents the incorporation of a second nucleotide into the ribose or deoxyribose moiety.

7. The nucleotide of claim 5 , wherein the cleavable linker prevents the incorporation of a second nucleotide into the ribose or deoxyribose moiety.

8. The nucleotide of claim 1 , which is a deoxyribonucleotide triphosphate and the azido protecting group is attached to the 3′ oxygen atom.

9. The nucleotide of claim 8 , wherein the detectable label is a fluorophore.

10. An oligonucleotide comprising at least one nucleotide of claim 1 .

11. The oligonucleotide of claim 10 , wherein at least one nucleotide of claim 1 is present at a terminal position of the oligonucleotide.

12. A method for determining the sequence of an immobilized target polynucleotide, comprising:

(a) monitoring the sequential incorporation of nucleotides complementary to the immobilized target polynucleotide, wherein each of the nucleotides independently is a nucleotide of claim 1 , and wherein the identity of each nucleotide incorporated is determined by detection of the detectable label linked to the base; and

(b) removing the detectable label from the base by cleavage of the cleavable linker;

wherein non-incorporated nucleotides are removed prior to detection and the detectable label is removed subsequent to detection.

13. The method of claim 12 , comprising a first step and a second step, wherein in the first step, a first composition comprising two different nucleotides is brought into contact with the target polynucleotide, non-incorporated nucleotides are removed prior to detection and the detectable label is removed subsequent to detection, and wherein in the second step, a second composition comprising two different nucleotides not included in the first composition is brought into contact with the target polynucleotide, and non-incorporated nucleotides are removed prior to detection and subsequent to removal of the label, and wherein the first step and the second step are optionally repeated one or more times.

14. The method of claim 12 , wherein four different nucleotides are supplied simultaneously.

15. The method of claim 12 , wherein each of the nucleotides comprises the azido protecting group at the 3′ oxygen atom of the ribose or deoxyribose.

16. The method of claim 15 , wherein the azido protecting group and the detectable label are removable using a single treatment.

17. The method of claim 12 , wherein the detectable label or the cleavable linker prevents the incorporation of a second nucleotide into the target polynucleotide.

18. The method of claim 12 , wherein the base is a pyrimidine, purine or deazapurine.

19. The method of claim 12 , wherein each of the nucleotides comprises a deoxyribose moiety.

20. The method of claim 12 , wherein the detectable label is a fluorophore.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 13, 2020
From: MILTON, JOHN; WU, XIAOLIN
To: ILLUMINA CAMBRIDGE LIMITED
Reel/Frame 051812/0782 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 21, 2019
From: MILTON, JOHN
To: ILLUMINA CAMBRIDGE LIMITED
Reel/Frame 051076/0578 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: WU, XIAOLIN
To: ILLUMINA CAMBRIDGE LIMITED
Reel/Frame 050844/0138 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 11, 2017
From: BALASUBRAMANIAN, SHAUKAR; BARNES, COLIN; LIU, XIAOHAI
To: ILLUMINA CAMBRIDGE LTD.
Reel/Frame 042340/0968 →
Priority Claims (1)
GB 0129012.1 · Dec 4, 2001 · national
Continuity (8)
Continuation 14821566 · Aug 7, 2015
Continuation 14094646 · Dec 2, 2013
Continuation 13437772 · Apr 2, 2012
Continuation 12804025 · Jul 13, 2010
Division 12283285 · Sep 9, 2008
Continuation 10497594
Continuation In Part 10227131 · Aug 23, 2002
Related Publication 20170204458A1 · Jul 20, 2017
Cited By (4)
US 12,241,891 US 12,331,356 US 12,540,350 US 12,612,660